On May 15, 2015, the FDA announced that it was investigating various diabetes drugs (SGLT2 inhibitors) after reports of the drug causing a condition known as ketoacidosis in patients.
Ketoacidosis is a serious medical condition that elevates the acid levels in a persons body. It is particularly dangerous in that it can cause a patient to go into a diabetic coma or even death.
One of the brand names is Invokana. There are reports that Invokana has caused ketoacidosis, kidney failure, heart attacks and even strokes in patients.
Other brand names include:
You can access the Medication Guide for Invokana here.
The lawsuits that are being filed across the country on behalf of injured victims of Invokana allege that the manufacturers and distributors failed to warn of the increased risks of injuries such as ketoacidosis, kidney failure, heart attack, stroke or other cardiovascular problems. Since the FDA never approved the use of Invokana for patients with type 1 diabetes, it is argued that had the manufacturer and distributor been truthful, then physicians would have had the chance to prescribe a different medication for diabetics.
The Torkzadeh Law Firm is currently investigating injuries and side effects in patients that used Invokana. If you or a loved one have been injured, contact us today and speak with one of our Invokana lawyers for a free legal consultation.